Filing Details

Accession Number:
0001127602-12-015817
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-05-03 18:01:47
Reporting Period:
2012-05-01
Filing Date:
2012-05-03
Accepted Time:
2012-05-03 18:01:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1073431 Life Technologies Corp LIFE Biological Products, (No Disgnostic Substances) (2836) 330373077
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1203767 G Bradley Lorimier 5791 Van Allen Way
Carlsbad CA 92008
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-05-01 20,000 $17.56 28,200 No 4 M Direct
Common Stock Disposition 2012-05-01 17,216 $46.48 10,984 No 4 S Direct
Common Stock Disposition 2012-05-01 2,784 $46.95 8,200 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options Disposition 2012-05-01 20,000 $0.00 20,000 $17.56
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2003-05-24 2012-05-24 No 4 M Direct
Footnotes
  1. Options exercised from Grant #4933 pursuant to 10b5-1 Trading Plan.
  2. Sale of common stock from exercise of Grant #4933 pursuant to 10b5-1 Trading Plan.
  3. Weighted average from 59 transactions with prices ranging from $45.95 to $46.92. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.
  4. Weighted average from 4 transactions with prices ranging from $46.94 to $46.96. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.